首页> 外文期刊>Ukrainian Biochemical Journal >The history of creation and study of vitamin D medicines in the Laboratory of Medical Biochemistry of the Palladin Institute of Biochemistry of the NAS of Ukraine for 1990-2015
【24h】

The history of creation and study of vitamin D medicines in the Laboratory of Medical Biochemistry of the Palladin Institute of Biochemistry of the NAS of Ukraine for 1990-2015

机译:1990-2015年在乌克兰NAS的Palladin生物化学研究所的医学生物化学实验室中创建和研究维生素D药物的历史

获取原文
       

摘要

The article presents the main results of inventive activity of the Laboratory of Medical Biochemistry headed by Dr. L. I. Apukhovska of the Palladin Institute of Biochemistry of the NAS of Ukraine. These researches continued the works initiated by Prof. V. P. Vendt and included development of technologies for the production of highly efficient preparations based on vitamin Dsub3/sub, namely “VIDEIN” in several modified forms (for prevention and treatment of rickets and rickets-like diseases in children, osteopathy of various origins, hypovitaminosis D in pregnant, mineral metabolism disorders, etc), water-soluble vitamin Dsub3/sub (for prevention and treatment of rickets in children from the first months of life), “KALMIVID” and ”KALMIVID-M” (for treatment of bone tissue diseases associated with mineral metabolism disorders), the pharmaceutical composition “MEBIVID” (for treatment of osteoporosis and diseases associated with reduced bone mineral density) and therapeutic vitamin-Dsub3/sub-E protein complex (for regulation of metabolic processes, improvement of structural and functional bone quality as well as structure and function of epiphyseal cartilage). All products are characterized by stability of vitamin Dsub3/sub molecule, and thus, dosing accuracy and reliability, whilst not containing toxic preservatives and stabilizers. The technologies for production as well as analytical and normative documentations have been developed for all preparations.
机译:本文介绍了由乌克兰NAS帕拉丁生物化学研究所的L. I. Apukhovska博士领导的医学生物化学实验室的发明活动的主要成果。这些研究是VP Vendt教授发起的工作的延续,包括开发基于维生素D 3 的高效制剂的技术开发,即几种修饰形式的“ VIDEIN”(用于预防和治疗儿童病和类病,各种原因的骨病,孕妇维生素D缺乏症,矿物质代谢紊乱等),水溶性维生素D 3 (用于预防和治疗儿童the病)生命的头几个月),“ KALMIVID”和“ KALMIVID-M”(用于治疗与矿物质代谢紊乱有关的骨组织疾病),药物组合物“ MEBIVID”(用于治疗骨质疏松症和与降低骨矿物质密度有关的疾病)和治疗性维生素D 3 -E蛋白复合物(用于调节代谢过程,改善骨的结构和功能质量以及of软骨的结构和功能)。所有产品均以维生素D 3 分子的稳定性为特征,因此,其剂量准确性和可靠性不包含有毒的防腐剂和稳定剂。已经为所有准备工作开发了生产技术以及分析和规范性文档。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号